Back

The efficacy, safety and immunogenicity Nanocovax: results of a randomized, double-blind, placebo-controlled Phase 3 trial.

2022-03-23 infectious diseases Title + abstract only
View on medRxiv
Show abstract

BackgroundNanocovax is a recombinant severe acute respiratory syndrome coronavirus 2 subunit vaccine composed of full-length prefusion stabilized recombinant SARS-CoV-2 spike glycoproteins (S-2P) and aluminum hydroxide adjuvant. In a Phase 1 and 2 studies, (NCT04683484) the vaccine was found to be safe and induce a robust immune response in healthy adult participants. MethodsWe conducted a multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety, immunogenicity, an...

Predicted journal destinations

1
New England Journal of Medicine
49 training papers
Top 0.1% 11.3%
2
Vaccines
131 training papers
Top 0.8% 8.6%
3
Vaccine
140 training papers
Top 1% 8.6%
4
The Lancet Infectious Diseases
57 training papers
#1 8.6%
5
Clinical Infectious Diseases
219 training papers
Top 4% 6.1%
6
PLOS ONE
1737 training papers
Top 83% 4.8%
7
Open Forum Infectious Diseases
124 training papers
Top 3% 3.7%
8
The Journal of Infectious Diseases
137 training papers
Top 4% 3.4%
9
Human Vaccines & Immunotherapeutics
20 training papers
#1 1.9%
10
International Journal of Infectious Diseases
115 training papers
Top 9% 1.9%
11
Frontiers in Immunology
140 training papers
Top 6% 1.9%
12
JAMA Network Open
125 training papers
Top 10% 1.9%
13
Nature Communications
483 training papers
Top 39% 1.9%
14
Clinical Microbiology and Infection
54 training papers
Top 2% 1.9%
15
eClinicalMedicine
55 training papers
Top 0.5% 1.9%
16
BMJ Open
553 training papers
Top 55% 1.5%
17
Frontiers in Medicine
99 training papers
Top 12% 1.5%
18
Scientific Reports
701 training papers
Top 89% 1.3%
19
Journal of Medical Virology
95 training papers
Top 9% 1.3%
20
Journal of Infection
64 training papers
Top 6% 1.1%
21
BMJ
49 training papers
Top 4% 1.1%
22
Nature Medicine
88 training papers
Top 14% 0.9%
23
eBioMedicine
82 training papers
Top 14% 0.7%
24
Viruses
79 training papers
Top 11% 0.7%
25
Emerging Infectious Diseases
84 training papers
Top 18% 0.7%
26
Infectious Diseases and Therapy
18 training papers
Top 0.9% 0.7%
27
BMC Medicine
155 training papers
Top 37% 0.7%
28
Journal of Clinical Virology
54 training papers
Top 8% 0.7%
29
BMC Infectious Diseases
110 training papers
Top 27% 0.7%
30
The Lancet Respiratory Medicine
16 training papers
Top 0.6% 0.7%